Crinetics Pharmaceuticals 2025 R&D Day


June 26, 2025

Please join the Crinetics management team for a R&D Day to discuss the Company’s proprietary in-house discovery engine and proven development approach for differentiated endocrine therapies.

The event will highlight Crinetics’ early-stage pipeline strategy and data to deliver sustainable long-term growth, with a focus on:

  • NETs and beyond – NDC platform with CRN09682
  • TSH antagonist for Graves’ disease and thyroid eye disease (TED)
  • SST3 agonist for autosomal dominant polycystic kidney disease (ADPKD)

Date:
June 26, 2025
Time:
9:00 AM EDT
Virtual Meeting:
Note: You must register to be eligible to
participate in the meeting.

REGISTER NOW